Skip to main content
Resources › Psychotropics A-Z › Olanzapine | Zyprexa | Zyprexa
Atypical Antipsychotic

Olanzapine | Zyprexa

Clinical Overview

Olanzapine is an atypical antipsychotic indicated for schizophrenia, bipolar I disorder (manic or mixed episodes), and as maintenance treatment for bipolar disorder. It is also available as a long-acting injection and in combination with fluoxetine for treatment-resistant depression and bipolar depression.

Primary Clinical Applications

Olanzapine is indicated for schizophrenia in adults and adolescents (13-17 years), acute treatment of manic or mixed episodes in bipolar I disorder, and maintenance treatment of bipolar disorder. It shows particular efficacy in preventing mood episodes and managing agitation.

Mechanism and Clinical Benefits

Olanzapine antagonizes multiple neurotransmitter receptors including dopamine D2, serotonin 5-HT2A, histamine H1, and muscarinic receptors. This broad receptor profile contributes to its efficacy but also to its side effect profile, particularly metabolic effects.

Formulation Options

Available as oral tablets, orally disintegrating tablets, intramuscular injection for agitation, and long-acting injection (Zyprexa Relprevv) for maintenance treatment. Each formulation offers specific advantages for different clinical situations.

Prescribing Information

Dosing & Administration

Schizophrenia – Adults:

  • Initial: 5-10 mg daily
  • Target: 10 mg daily
  • Range: 10-20 mg daily

Schizophrenia – Adolescents:

  • Initial: 2.5-5 mg daily
  • Target: 10 mg daily
  • Range: 2.5-20 mg daily

Bipolar I Disorder – Manic Episodes:

  • Initial: 10-15 mg daily
  • Range: 5-20 mg daily

Bipolar Maintenance:

  • Range: 5-20 mg daily

Agitation (IM):

  • Initial: 10 mg IM
  • Additional doses: 5-10 mg IM (maximum 30 mg/day)

Indications

  • Schizophrenia (adults and adolescents ≥13 years)
  • Bipolar I disorder – manic or mixed episodes
  • Bipolar disorder maintenance treatment
  • Agitation associated with schizophrenia or bipolar I disorder

Contraindications

  • Known hypersensitivity to olanzapine

Warnings & Precautions

  • Boxed Warning: Increased mortality in elderly patients with dementia-related psychosis
  • Metabolic changes: Weight gain, hyperglycemia, dyslipidemia
  • Neuroleptic malignant syndrome: Discontinue if suspected
  • Tardive dyskinesia: Risk increases with duration
  • Orthostatic hypotension: Monitor blood pressure
  • Seizures: Use caution in patients with seizure history

Drug Interactions

  • CNS depressants: Enhanced sedation
  • Anticholinergic drugs: Additive anticholinergic effects
  • Dopamine agonists: Antagonistic effects
  • Fluvoxamine: Increased olanzapine levels
  • Carbamazepine: Decreased olanzapine levels

Adverse Reactions

Common (≥5%):

  • Weight gain, somnolence, dizziness, increased appetite

Metabolic:

  • Hyperglycemia, dyslipidemia, hyperprolactinemia

Special Populations

  • Elderly: Increased mortality risk in dementia patients
  • Pregnancy: Use only if benefits outweigh risks
  • Hepatic impairment: Consider lower starting dose
  • Adolescents: Monitor weight and metabolic parameters closely
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.